# Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

> **NCT01295645** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 27 (actual)

## Conditions studied

- Transplantation Infection

## Interventions

- **DRUG:** Cidofovir
- **OTHER:** No Cidofovir

## Key facts

- **NCT ID:** NCT01295645
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2011-03-17
- **Primary completion:** 2028-03-15
- **Final completion:** 2028-03-15
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01295645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01295645, "Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01295645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*